Regent Peak Wealth Advisors LLC Sells 122 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Regent Peak Wealth Advisors LLC cut its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 5.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 2,005 shares of the financial services provider’s stock after selling 122 shares during the quarter. Regent Peak Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $265,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of IBB. Security National Bank of SO Dak boosted its holdings in shares of iShares Biotechnology ETF by 0.7% in the second quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after buying an additional 75 shares during the period. SPC Financial Inc. boosted its stake in iShares Biotechnology ETF by 2.4% in the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after purchasing an additional 75 shares during the period. Werba Rubin Papier Wealth Management increased its holdings in iShares Biotechnology ETF by 2.7% during the 3rd quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after purchasing an additional 76 shares in the last quarter. Main Street Financial Solutions LLC increased its holdings in iShares Biotechnology ETF by 1.0% during the 2nd quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock worth $1,098,000 after purchasing an additional 82 shares in the last quarter. Finally, HCR Wealth Advisors raised its stake in shares of iShares Biotechnology ETF by 0.6% in the 2nd quarter. HCR Wealth Advisors now owns 13,453 shares of the financial services provider’s stock valued at $1,847,000 after purchasing an additional 83 shares during the period. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 1.2 %

Shares of IBB stock traded up $1.65 on Tuesday, hitting $135.94. 953,315 shares of the stock were exchanged, compared to its average volume of 1,000,672. The business has a 50-day moving average of $138.56 and a 200 day moving average of $142.11. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.